       Document 0526
 DOCN  M9440526
 TI    The global diffusion of injecting drug use: implications for human
       immunodeficiency virus infection.
 DT    9404
 AU    Stimson GV; Department of Psychiatry, Charing Cross and Westminster
       Medical; School, London.
 SO    Bull Narc. 1993;45(1):3-17. Unique Identifier : AIDSLINE MED/94138315
 AB    Long-standing patterns of drug injecting in mainly developed countries
       have been joined by the introduction and expansion of drug injecting in
       developing countries, often followed quickly by outbreaks of human
       immunodeficiency virus (HIV) infection. Drug injecting has been
       identified in 80 countries and HIV infection in 52 of these. Given the
       continued recruitment of new injectors where injecting is endemic, the
       diffusion of drug injecting in countries where the practice was formerly
       rare and the potential for this diffusion to occur, HIV prevention must
       also consider interventions that discourage drug injecting. Particularly
       at risk are countries in drug-producing regions and along drug transit
       routes in Africa, south-east and south-west Asia and South America.
       Injecting can spread in less time than it takes to introduce HIV
       prevention activities. The task of the public health system will be to
       find a balance between activities targeted at helping current injectors
       change their behaviour and activities targeted at discouraging the
       adoption of drug injecting.
 DE    *Developing Countries  *Disease Outbreaks  Human  HIV
       Infections/*EPIDEMIOLOGY/*ETIOLOGY/PREVENTION & CONTROL  Public Health
       Administration  Research  Risk Factors  Substance Abuse,
       Intravenous/*COMPLICATIONS/*EPIDEMIOLOGY/  PREVENTION & CONTROL  *World
       Health  JOURNAL ARTICLE  REVIEW  REVIEW LITERATURE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

